MS News From the AAN & CMSC Annual Meetings

Article Type
Changed
Tue, 05/21/2019 - 12:14
Article PDF
Publications
Topics
Sections
Article PDF
Article PDF
Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Article PDF Media

Best Practices: Understanding the Role of Delayed Cord Clamping During Cord Blood Collection

Article Type
Changed
Tue, 05/05/2020 - 17:25
Display Headline
Best Practices: Understanding the Role of Delayed Cord Clamping During Cord Blood Collection
This supplement is sponsored by Cbr Systems, Inc.

Click Here to Read Supplement. 

Topics Include:

  • The Role of Cord Blood Stem Cells
  • Impact of DCC in Cord Blood Collection
  • Combining DCC and Cord Blood Collection
  • When to Clamp the Umbilical Cord

 

Faculty/Faculty Disclosure:

Fung Lam, MD
Chair-GYN Quality, Director of Medical Education (OB-GYN), California-Pacific Medical Center
Senior Partner, Golden Gate Obstetrics & Gynecology
Clinical Professor-Department of Obstetrics, Gynecology and Reproductive Sciences
University of California, San Francisco
San Francisco, California

 

Click Here to Read the Supplement. 

Sponsor
Publications
Sections
Sponsor
Sponsor
This supplement is sponsored by Cbr Systems, Inc.
This supplement is sponsored by Cbr Systems, Inc.

Click Here to Read Supplement. 

Topics Include:

  • The Role of Cord Blood Stem Cells
  • Impact of DCC in Cord Blood Collection
  • Combining DCC and Cord Blood Collection
  • When to Clamp the Umbilical Cord

 

Faculty/Faculty Disclosure:

Fung Lam, MD
Chair-GYN Quality, Director of Medical Education (OB-GYN), California-Pacific Medical Center
Senior Partner, Golden Gate Obstetrics & Gynecology
Clinical Professor-Department of Obstetrics, Gynecology and Reproductive Sciences
University of California, San Francisco
San Francisco, California

 

Click Here to Read the Supplement. 

Click Here to Read Supplement. 

Topics Include:

  • The Role of Cord Blood Stem Cells
  • Impact of DCC in Cord Blood Collection
  • Combining DCC and Cord Blood Collection
  • When to Clamp the Umbilical Cord

 

Faculty/Faculty Disclosure:

Fung Lam, MD
Chair-GYN Quality, Director of Medical Education (OB-GYN), California-Pacific Medical Center
Senior Partner, Golden Gate Obstetrics & Gynecology
Clinical Professor-Department of Obstetrics, Gynecology and Reproductive Sciences
University of California, San Francisco
San Francisco, California

 

Click Here to Read the Supplement. 

Publications
Publications
Article Type
Display Headline
Best Practices: Understanding the Role of Delayed Cord Clamping During Cord Blood Collection
Display Headline
Best Practices: Understanding the Role of Delayed Cord Clamping During Cord Blood Collection
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.

Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes

Article Type
Changed
Tue, 05/03/2022 - 15:29
Display Headline
Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes

While type 2 diabetes (T2D) is commonly seen in primary care, it is difficult to control successfully over time. This series offers brief eNewsletters written by clinical experts that are designed to assist in the clinical management of patients with T2D.
 
This fourth eNewsletter in the series, entitled Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes, was written by Szymon L. Wiernek, MD, PhD, and Matthew A. Cavender, MD, MPH. It presents an overview of commonly used non–insulin-based glucose-lowering drugs in the context of cardiovascular disease risk. The basic mechanisms of action for each pharmacotherapeutic class and the effects of these medications on cardiovascular events are discussed so that physicians can make informed treatment decisions

Click here to read the supplement

Szymon L. Wiernek, MD, PhD 

Department of Medicine University of North Carolina-Chapel Hill 
Chapel Hill, NC 

 

 

 


Matthew A. Cavender, MD, MPH 

Department of Medicine University of North Carolina-Chapel Hill 
Chapel Hill, NC

Sponsor
Funding for this newsletter series was provided by AstraZeneca
Publications
Topics
Sections
Sponsor
Funding for this newsletter series was provided by AstraZeneca
Sponsor
Funding for this newsletter series was provided by AstraZeneca

While type 2 diabetes (T2D) is commonly seen in primary care, it is difficult to control successfully over time. This series offers brief eNewsletters written by clinical experts that are designed to assist in the clinical management of patients with T2D.
 
This fourth eNewsletter in the series, entitled Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes, was written by Szymon L. Wiernek, MD, PhD, and Matthew A. Cavender, MD, MPH. It presents an overview of commonly used non–insulin-based glucose-lowering drugs in the context of cardiovascular disease risk. The basic mechanisms of action for each pharmacotherapeutic class and the effects of these medications on cardiovascular events are discussed so that physicians can make informed treatment decisions

Click here to read the supplement

Szymon L. Wiernek, MD, PhD 

Department of Medicine University of North Carolina-Chapel Hill 
Chapel Hill, NC 

 

 

 


Matthew A. Cavender, MD, MPH 

Department of Medicine University of North Carolina-Chapel Hill 
Chapel Hill, NC

While type 2 diabetes (T2D) is commonly seen in primary care, it is difficult to control successfully over time. This series offers brief eNewsletters written by clinical experts that are designed to assist in the clinical management of patients with T2D.
 
This fourth eNewsletter in the series, entitled Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes, was written by Szymon L. Wiernek, MD, PhD, and Matthew A. Cavender, MD, MPH. It presents an overview of commonly used non–insulin-based glucose-lowering drugs in the context of cardiovascular disease risk. The basic mechanisms of action for each pharmacotherapeutic class and the effects of these medications on cardiovascular events are discussed so that physicians can make informed treatment decisions

Click here to read the supplement

Szymon L. Wiernek, MD, PhD 

Department of Medicine University of North Carolina-Chapel Hill 
Chapel Hill, NC 

 

 

 


Matthew A. Cavender, MD, MPH 

Department of Medicine University of North Carolina-Chapel Hill 
Chapel Hill, NC

Publications
Publications
Topics
Article Type
Display Headline
Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes
Display Headline
Effect of Non–Insulin-Based Glucose-Lowering Therapies on Cardiovascular Outcomes in Patients With Type 2 Diabetes
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Off
Use ProPublica

Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer

Article Type
Changed
Tue, 05/21/2019 - 12:14
Display Headline
Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer

This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.

Click here to read the supplement

Jennifer Banfield, APRN, FNP

Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska

 

Kevin R. Murphy, MD

Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska

Sponsor
Funding for this newsletter series was provided by AstraZeneca
Publications
Topics
Sections
Sponsor
Funding for this newsletter series was provided by AstraZeneca
Sponsor
Funding for this newsletter series was provided by AstraZeneca

This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.

Click here to read the supplement

Jennifer Banfield, APRN, FNP

Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska

 

Kevin R. Murphy, MD

Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska

This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.

Click here to read the supplement

Jennifer Banfield, APRN, FNP

Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska

 

Kevin R. Murphy, MD

Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska

Publications
Publications
Topics
Article Type
Display Headline
Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer
Display Headline
Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Off

Highlights from The 2017 Society of Gynecologic Surgeons Scientific Meeting

Article Type
Changed
Tue, 05/21/2019 - 12:14
Display Headline
Highlights from The 2017 Society of Gynecologic Surgeons Scientific Meeting

PART 1

Robert E. Gutman, MD
FPMRS Program Director
MedStar Washington Hospital Center
Associate Professor
Departments of Urology and Obstetrics/Gynecology
Georgetown University
Washington, DC

Elizabeth R. Mueller, MD, MSME
Professor, Departments of Urology and Obstetrics/Gynecology
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois

Janet Bickel, MA
Leadership and Career Development Coach
Falls Church, Virginia

Kristin M. Jacobs, MD
Steering Committee Chair, AUGS-SGS Group of FPRN®
FPMRS Fellow, Division of Urogynecology and Reconstructive Pelvic Surgery
Brown University
Providence, Rhode Island

Lior Lowenstein, MD, MS, MHA
Clinical Associate Professor, Department of Obstetrics and Gynecology
Rambam Health Center Campus, Ruth and Bruce Rappaport Faculty of Medicine
Technion Israel Institute of Technology
Haifa, Israel


Drs. Gutman, Jacobs, and Lowenstein and Ms. Bickel report no financial relationships relevant to their articles. Dr. Mueller reports that she is an investigator for and is on the advisory board of Astellas Medical and Scientific Affairs.

Photo: 3D4Medical / Science Source

PART 2

Geoffrey W. Cundiff, MD
Dr. Victor Gomel Professor and Head
Department of Obstetrics and Gynaecology
University of Bristish Columbia
Vancouver, British Columbia

Kimberly Kenton, MD,  MS
Professor, Obstetrics and Gynaecology and Urology
Divison Chief and Fellowship Program Director
Female Pelvis Medicine and Reconstructive Surgery
Medicial Director, Women's Integrated Pelvic Health Program
Northwestern Medicine/Northwestern University Feinberg School of Medicince
Chicago, Illinois

Denise M. Elser, MD
Urogynecologist
Women's Health Institute of Illinois
Oak Lawn, Illinois


Drs. Cundiff and Elser report no financial relationships relevant to their articles. Dr. Kenton reports that she receives grant or research support from Boston Scientific and the National Institutes of Health, and that she serves as an expert witness for the Butler Snow Law Firm/Ethicon.

Illustration: Science Picture Co/ Science Source

Article PDF
Publications
Sections
Article PDF
Article PDF

PART 1

Robert E. Gutman, MD
FPMRS Program Director
MedStar Washington Hospital Center
Associate Professor
Departments of Urology and Obstetrics/Gynecology
Georgetown University
Washington, DC

Elizabeth R. Mueller, MD, MSME
Professor, Departments of Urology and Obstetrics/Gynecology
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois

Janet Bickel, MA
Leadership and Career Development Coach
Falls Church, Virginia

Kristin M. Jacobs, MD
Steering Committee Chair, AUGS-SGS Group of FPRN®
FPMRS Fellow, Division of Urogynecology and Reconstructive Pelvic Surgery
Brown University
Providence, Rhode Island

Lior Lowenstein, MD, MS, MHA
Clinical Associate Professor, Department of Obstetrics and Gynecology
Rambam Health Center Campus, Ruth and Bruce Rappaport Faculty of Medicine
Technion Israel Institute of Technology
Haifa, Israel


Drs. Gutman, Jacobs, and Lowenstein and Ms. Bickel report no financial relationships relevant to their articles. Dr. Mueller reports that she is an investigator for and is on the advisory board of Astellas Medical and Scientific Affairs.

Photo: 3D4Medical / Science Source

PART 2

Geoffrey W. Cundiff, MD
Dr. Victor Gomel Professor and Head
Department of Obstetrics and Gynaecology
University of Bristish Columbia
Vancouver, British Columbia

Kimberly Kenton, MD,  MS
Professor, Obstetrics and Gynaecology and Urology
Divison Chief and Fellowship Program Director
Female Pelvis Medicine and Reconstructive Surgery
Medicial Director, Women's Integrated Pelvic Health Program
Northwestern Medicine/Northwestern University Feinberg School of Medicince
Chicago, Illinois

Denise M. Elser, MD
Urogynecologist
Women's Health Institute of Illinois
Oak Lawn, Illinois


Drs. Cundiff and Elser report no financial relationships relevant to their articles. Dr. Kenton reports that she receives grant or research support from Boston Scientific and the National Institutes of Health, and that she serves as an expert witness for the Butler Snow Law Firm/Ethicon.

Illustration: Science Picture Co/ Science Source

PART 1

Robert E. Gutman, MD
FPMRS Program Director
MedStar Washington Hospital Center
Associate Professor
Departments of Urology and Obstetrics/Gynecology
Georgetown University
Washington, DC

Elizabeth R. Mueller, MD, MSME
Professor, Departments of Urology and Obstetrics/Gynecology
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois

Janet Bickel, MA
Leadership and Career Development Coach
Falls Church, Virginia

Kristin M. Jacobs, MD
Steering Committee Chair, AUGS-SGS Group of FPRN®
FPMRS Fellow, Division of Urogynecology and Reconstructive Pelvic Surgery
Brown University
Providence, Rhode Island

Lior Lowenstein, MD, MS, MHA
Clinical Associate Professor, Department of Obstetrics and Gynecology
Rambam Health Center Campus, Ruth and Bruce Rappaport Faculty of Medicine
Technion Israel Institute of Technology
Haifa, Israel


Drs. Gutman, Jacobs, and Lowenstein and Ms. Bickel report no financial relationships relevant to their articles. Dr. Mueller reports that she is an investigator for and is on the advisory board of Astellas Medical and Scientific Affairs.

Photo: 3D4Medical / Science Source

PART 2

Geoffrey W. Cundiff, MD
Dr. Victor Gomel Professor and Head
Department of Obstetrics and Gynaecology
University of Bristish Columbia
Vancouver, British Columbia

Kimberly Kenton, MD,  MS
Professor, Obstetrics and Gynaecology and Urology
Divison Chief and Fellowship Program Director
Female Pelvis Medicine and Reconstructive Surgery
Medicial Director, Women's Integrated Pelvic Health Program
Northwestern Medicine/Northwestern University Feinberg School of Medicince
Chicago, Illinois

Denise M. Elser, MD
Urogynecologist
Women's Health Institute of Illinois
Oak Lawn, Illinois


Drs. Cundiff and Elser report no financial relationships relevant to their articles. Dr. Kenton reports that she receives grant or research support from Boston Scientific and the National Institutes of Health, and that she serves as an expert witness for the Butler Snow Law Firm/Ethicon.

Illustration: Science Picture Co/ Science Source

Publications
Publications
Article Type
Display Headline
Highlights from The 2017 Society of Gynecologic Surgeons Scientific Meeting
Display Headline
Highlights from The 2017 Society of Gynecologic Surgeons Scientific Meeting
Sections
Inside the Article

Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Use ProPublica
Article PDF Media

Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs

Article Type
Changed
Tue, 05/21/2019 - 12:14
Display Headline
Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs

This newsletter, Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs, discusses the characteristics and burden of mild persistent asthma and provides practical information on its diagnosis and appropriate management.

Click here to read the supplement

Gabriel Ortiz, MPAS, DFAAPA,
PA-C


Former American Academy of Physician Assistants (AAPA) Liaison to the American Academy of Allergy Asthma and Immunology (AAAAI) and former Liaison from AAAAI to the AAPA. 

Sponsor
Funding for this newsletter series was provided by AstraZeneca
Publications
Topics
Sections
Sponsor
Funding for this newsletter series was provided by AstraZeneca
Sponsor
Funding for this newsletter series was provided by AstraZeneca

This newsletter, Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs, discusses the characteristics and burden of mild persistent asthma and provides practical information on its diagnosis and appropriate management.

Click here to read the supplement

Gabriel Ortiz, MPAS, DFAAPA,
PA-C


Former American Academy of Physician Assistants (AAPA) Liaison to the American Academy of Allergy Asthma and Immunology (AAAAI) and former Liaison from AAAAI to the AAPA. 

This newsletter, Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs, discusses the characteristics and burden of mild persistent asthma and provides practical information on its diagnosis and appropriate management.

Click here to read the supplement

Gabriel Ortiz, MPAS, DFAAPA,
PA-C


Former American Academy of Physician Assistants (AAPA) Liaison to the American Academy of Allergy Asthma and Immunology (AAAAI) and former Liaison from AAAAI to the AAPA. 

Publications
Publications
Topics
Article Type
Display Headline
Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs
Display Headline
Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Off

Highlights From the 69th Annual Meeting of the American Academy of Neurology

Article Type
Changed
Tue, 05/21/2019 - 12:14

Selected highlights from the 69th Annual Meeting of the American Academy of Neurology

Publications
Sections

Selected highlights from the 69th Annual Meeting of the American Academy of Neurology

Selected highlights from the 69th Annual Meeting of the American Academy of Neurology

Publications
Publications
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Use ProPublica